DLX — Hemagglutination Inhibition, Barbiturate Class II
FDA product code DLX covers "Hemagglutination Inhibition, Barbiturate", a Class II medical device regulated under 21 CFR 862.3150. Submissions are reviewed by the Clinical Toxicology panel.
Classification Details
- Product Code
- DLX
- Device Class
- Class II
- Regulation Number
- 862.3150
- Submission Type
- Review Panel
- TX
- Medical Specialty
- Clinical Toxicology
- Implant
- No